Codoxime
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(((4,5α-Epoxy-3-methoxy-17-methylmorphinan-6-ylidene)amino)oxy)acetic acid | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 7125-76-0 |
| ATC code | none |
| PubChem | CID 9570253 |
| ChemSpider | 7844721 |
| UNII |
JT5I2F57F7 |
| KEGG | D03581 |
| ChEMBL | CHEMBL2107300 |
| Synonyms | Codoxime |
| Chemical data | |
| Formula | C20H24N2O5 |
| Molar mass | 372.415 g/mol |
| |
Codoxime (Codossima) is an opiate analogue that is a derivative of hydrocodone, where the 6-ketone group has been replaced by carboxymethyloxime. It has primarily antitussive effects[1] and was found to have moderate potential to cause dependence in animal studies.[2]
References
- ↑ Jack Fishman. Morphinone and Codeinone Derivatives. US Patent 3153042
- ↑ Jasinski DR, Martin WR. Assessment of the dependence-producing properties of dihydrocodeinone and codoxime. Clinical Pharmacology and Therapeutics. 1967 Mar-Apr;8(2):266-70. PMID 6021586
This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
